Caudal Dexmedetomidine vs Ketamine for Postoperative Analgesia in Pediatric DDH Surgery

Starting soon · Not applicable

Conditions studied: Developmental Dysplasia of the Hip

In brief

This study compares two medicines, Dexmedetomidine and Ketamine, added to caudal Bupivacaine to control pain after hip surgery in children. We will check how well each medicine reduces pain, how long the pain relief lasts, and if children need extra pain medicine. The goal is to find the safest and most effective option for postoperative pain relief in children undergoing hip surgery.

Key facts

Study ID

NCT07385352

Run by

Assiut University

People needed

54

Starts

2026-03-01

Expected to finish

2026-09-01

Last updated by the study team

2026-02-04

Who can join

Age: 1 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children aged 1 to 6 years undergoing surgery for developmental dysplasia of the hip
• ASA physical status I or II
• Parental or guardian informed consent obtained

You may not qualify if…

• Known allergy to local anesthetics, Dexmedetomidine, or Ketamine
• Coagulopathy or bleeding disorders
• Infection at the site of caudal injection
• Neurological disorders
• Severe systemic disease
• Refusal of parental consent

Where it is running

• Assiut University Hospital — Asyut, Asyut Governorate, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.